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Introduction
Secundum-type atrial septal defects (ASDs) account for
10% of all cases of congenital heart disease. In recent
years, transcatheter device closure has become an effec-
tive and safe alternative for treating ASDs.1–4 Accurate
measurement of the size of the defect is essential for
transcatheter closure. Conventional methods to measure
these defects include transthoracic echocardiography
(TTE), transesophageal echocardiography (TEE), and
angiocardiography. The balloon-stretched diameter
measured by using a sizing plate has been considered
as the criterion standard for device selection.5,6 TEE
improves assessment of the size, number and position
of the defects over traditional TTE. In addition, TEE
can be used to effectively evaluate the surrounding
structures and septal rims. It has also been useful for
monitoring and guiding device-deployment proce-
dures.2,5,7 However, the need for general anesthesia and
endotracheal intubation creates potential discomfort
and risk for patients.
Several studies have recently demonstrated that
intracardiac echocardiography (ICE) using a diagnostic
ultrasound catheter (AcuNav; Acuson Corp., Mountain
View, CA, USA) is better than TEE for transcatheter
device closure of ASDs.8–13 Advantages of ICE include:
(1) a capacity for multiplanar and high-quality, near-field
imaging using a steerable quadridirectional catheter; (2)
shortened fluoroscopy, procedural, and recovery times
because only local anesthesia is required; (3) no patient
discomfort from general anesthesia or endotracheal
intubation; and (4) no risk of airway or esophageal
perforation, as is associated with TEE. However, to
our knowledge, the correlation between the maximal,
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nonstretched defect diameter measured with different
methods and the balloon-stretched diameter based
on sizing plates has not been discussed previously.
Therefore, the aim of this study was to evaluate the
accuracy of measuring ASDs by using ICE and to
compare these measurements with those obtained with
conventional methods.
Methods
Study population
Between January 2004 and December 2006, 292
patients with a secundum ASD were admitted for tran-
scatheter device closure at 3 medical centers (Taipei,
Taichung, and Kaohsiung Veterans General Hospitals).
Before the procedure, all patients underwent TTE to
investigate the type and size of interatrial communica-
tion. Informed consent was obtained from patients or
from parents if patients were younger than 18 years.
Procedures were guided by TEE in 154 patients
(group I) and by ICE in 138 (group II). The patients
were not randomly distributed. Rather, TEE was per-
formed in those treated before April 2005, and ICE
was performed after April 2005, when the AcuNav
catheter (Acuson Corp.) became available. All patients
underwent TTE and cardiac catheterization (cinean-
giography and balloon sizing) to evaluate the ASD.
Patients who had defects measuring ≥ 3 mm, as deter-
mined with TEE or ICE, and who were at least 2 years
old and who weighed at least 12 kg were eligible for
transcatheter device closure. Patients with multiple
fenestrated ASDs, balloon-stretched defect diameters
> 38 mm, and other clinically significant associated
cardiac malformations (anomalous pulmonary venous
return) were excluded from the study because they
might impose difficulties in transcatheter closure, with
higher risk of residual leak, distal migration and defor-
mity of the device and a certain failure rate percentage.
The maximal diameter of the nonstretched defects
and the stretched defects measured by using the dif-
ferent techniques were compared with the criterion
standard of the sizing-plate diameter.
TTE evaluation
Two-dimensional and color Doppler echocardiograms
were recorded using a Sonos 7500 ultrasound system
(Hewlett-Packard, Andover, MA, USA) with a 4- or
8-MHz transducer. Conventional short-axis, 4-chamber,
and subcostal views of the atrial septum were obtained
to measure the diameter of the ASD. The largest diam-
eter obtained from the different views was recorded
as the TTE measurement of the ASD diameter. The
surrounding rims of the defect were also measured,
including the relation to superior and inferior vena
cava inflow (superoposterior and inferoposterior rim)
aspects of the interatrial septum, the right pulmonary
vein, the retroaortic region (superoanterior rim), and
the atrioventricular valves (inferoanterior rim).
Echocardiographic guidance
Patients in group I received general anesthesia with
endotracheal intubation. TEE images were obtained by
using a multiplanar TEE probe with a 5-MHz phased-
array transducer and the ultrasonography system Sonos
7500 (Hewlett-Packard) in the standard transverse
(0–60°) and longitudinal (90–120°) views. The maximal
diameter of the defect was measured and recorded.
Group II patients received conscious sedation with-
out endotracheal intubation. ICE images were obtained
by using a 10F (3.2 mm), 5.5-MHz to 10-MHz
ultrasound-tipped AcuNav catheter (Acuson Corp.).
The catheter tip contained a 64-element, vector phased-
array transducer that scanned in the longitudinal plane
to provide a 90-sector image with tissue penetration
of 12 cm. The catheter was connected to an ultra-
sonography unit (Sequoia 256; Acuson Corp.) that
was equipped with special software for ICE. The ICE
catheter was introduced through a separate 11F sheath
in the same femoral vein in patients weighing more than
35 kg or from the left femoral vein in patients weighing
less than 35 kg. The catheter was advanced through
the inferior vena cava into the right atrium under flu-
oroscopic guidance. By using 4-way articulation, the
catheter was flexed posteriorly (posterior/anterior knob
rotated counterclockwise) and rotated rightward (right-
left knob rotated clockwise). This view corresponded
to the long-axis view and delineated the atrial septum
from the entry of the superior vena cava to the inferior
portion of the septum, the entire left atrium, and the
entry of the left pulmonary vein. To demonstrate the
aortic root and the relationship of the ASD to the aortic
valve, the entire catheter was rotated clockwise until
the ultrasonographic array was near the opening of the
tricuspid valve. This view corresponded to the short-axis
view. Standard long-axis and short-axis views were
acquired to best see the ASD and device deployment,
as well as to assess results of the closure.
The largest ASD diameter measured from these
views was recorded as the ICE measurement.
Closure protocol
The Amplatzer septal occluder (AGA Medical Corp.,
Golden Valley, MN, USA) was used in all patients. The
device-closure protocol and techniques have been pre-
viously described.1,7,14 In brief, the device was selected
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on the basis of the type and size of the interatrial septal
defect we measured. Patients were given systemic antico-
agulation at the time of the procedure with intravenous
heparin 50–100 U/kg to attain an activated clotting
time of longer than 200 seconds. Routine cardiac cath-
eterization and hemodynamic measurements were
performed from the femoral vein to assess the degree of
shunting and evaluate pulmonary vascular resistance.
The ratio of pulmonary-to-systemic blood flow (Qp/Qs
ratio) was calculated by applying the Fick principle. We
performed right upper pulmonary venography with
20–70° left anterior oblique and 20–35° cranial views
to define the location and size of the ASD. The maximal
diameters of the defects and surrounding rims were
completely evaluated, and the balloon-stretched diam-
eters of the defects were measured and compared
with those observed during ICE, TEE and quantitative
fluoroscopy.
A 24-mm or 34-mm balloon catheter (AGA Medical
Corp.) was used to measure the stretched diameter of
the defect. After it was filled with contrast medium
diluted 1:4, the balloon was pulled through the defect
and inflated until shunting was eliminated on TEE or
ICE images or until a waist was visible on fluoroscopic
images to prevent oversizing the defect. Using the waist
of the balloon measurements, we chose the size of the
sizing plate and selected an adequate device for closure.
Device deployment was guided by continuous ICE or
TEE and by fluoroscopy as needed. Venous sheaths
were removed once the activated clotting time was less
than 150 seconds.
Statistical analysis
Data are expressed as mean ± standard deviation. The
clinical parameters of the 2 groups were compared by
applying unpaired Student’s t test. Measurements of the
maximal nonstretched and balloon-stretched diameters
of the defects were compared with a sizing plate by using
regression lines and plotting scattergrams (SigmaPlot
9.0). Pearson’s correlation coefficients were calculated.
A p value of less than 0.05 indicated statistical signifi-
cance. Intraclass correlation coefficients were calculated
for balloon-stretched diameters determined with ICE
and with the sizing plate and for predicted and measured
sizing-plate sizes by using SPSS version 12.0 (SPSS Inc.,
Chicago, IL, USA).
Results
Demographic, hemodynamic, and echocardiographic
data for both patient groups are summarized in Table 1.
In group I, 142 patients successfully underwent sizing
and transcatheter device closure of their ASDs under
TEE guidance. Four patients were excluded because of
multiple ASDs, 4 because of excessively large defects
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Table 1. Demographic, hemodynamic and echocardiographic data of the 270 patients*
Group I (n = 142) Group II (n = 128) p
Age (yr) 15.3 ± 14.9 (2.0–72) 20.9 ± 16.8 (3.2–66) 0.002†
Body weight (kg) 35.1 ± 18.6 (12–86) 45.3 ± 17.3 (13–79) 0.001†
Qp/Qs 2.2 ± 1.0 (1.1–5.4) 2.1 ± 1.1 (1.0–5.6) 0.700
Defect size (mm) 0.120
TTE 12.9 ± 5.6 (3.3–30) 14.0 ± 5.9 (2.5–30)
ICE 14.3 ± 7.3 (3.0–31.7)
TEE 14.2 ± 6.4 (3.0–30)
Angiography 15.2 ± 6.6 (4.5–35.7) 15.4 ± 7.3 (2.7–35.1) 0.770
Stretched balloon diameter (mm)
ICE 19.4 ± 7.4 (5.9–37.8)
TEE 19.1 ± 6.9 (8.2–37)
Angiography 19.3 ± 7.5 (4.3–37.6) 19.5 ± 7.8 (6.2–37.9) 0.820
Sizing-plate diameter (mm) 18.9 ± 7.1 (5.0–38) 19.4 ± 7.4 (5.0–38) 0.560
Device size (mm) 19.5 ± 7.6 (7.0–38) 19.4 ± 8.4 (5.0–38) 0.930
Fluoroscopy time (min) 18.4 ± 7.9 (3.8–40) 14.14 ± 5.8 (3.7–25.8) 0.001†
Procedure time (min) 70.6 ± 22.2 (31–120) 60.6 ± 13.8 (22–88) 0.001†
*Data presented as mean ± standard deviation (range); †p < 0.05 was regarded as statistical significance. Qp/Qs = pulmonary-to-systemic blood flow ratio; 
TTE = transthoracic echocardiography; ICE = intracardiac echocardiography; TEE = transesophageal echocardiography.
and deficient rims, 3 because of an associated partial
anomalous pulmonary venous return, and 1 because of
an excessively small ASD. TEE-derived ASD diameters
correlated well with diameters measured with other
methods, both before and during balloon stretching.
In group II, 128 patients successfully underwent
sizing and transcatheter device closure of their ASDs
under ICE guidance. Five patients were excluded
because of an unexpectedly large defect and deficient
rims, 3 because of multiple ASDs, and 2 because of an
associated partial anomalous pulmonary venous return.
ICE-derived ASD diameters were significantly correlated
with diameters measured with other methods, both
before and during balloon stretching. Balloon-stretched
diameters measured with ICE significantly agreed with
sizing-plate sizes (Ri = 0.975; 95% confidence interval,
0.965, 0.983; p < 0.001).
The 2 groups did not significantly differ in terms
of the Qp/Qs ratio (p = 0.7), ASD diameters meas-
ured with TTE (p = 0.119) or angiography (p = 0.769),
balloon-stretched diameters measured with angiography
(p = 0.82), sizing-plate diameters (p = 0.56), or device
selection (p = 0.93). However, a significant difference
was found for patients’ age (p<0.002) and body weight
(p < 0.001).
The sizing-plate diameter of the ASD could be
estimated as follows: (ICE diameter × 1.07) +3.23 mm
(r=0.96, p<0.001), (TEE diameter ×1.05)+4.08mm
(r = 0.91, p < 0.001), (angiographic diameter × 0.94) +
4.50 mm (r = 0.88, p < 0.001), and (TTE diameter
× 1.07) + 4.43 mm (r = 0.85, p < 0.001).
Correlation was better between sizing-plate diame-
ters and ICE-measured ASDs than with ASDs measured
with the other methods (Figure 1). Also, good corre-
lation (r = 0.975; p < 0.001) and significant agreement
(Ri = 0.974; 95% confidence interval, 0.963, 0.982;
p < 0.001) were observed between the predicted and
measured sizing-plate diameters (Figure 2).
Times for both fluoroscopy (14.1 ± 5.8 vs. 18.4 ±
7.9 min, p < 0.001) and the procedure were shorter in
group II than in group I (60.6±13.8 vs. 70.6±22.2min,
p < 0.001) (Table 1). After the device was released,
TEE revealed 6 trivial and 2 mild immediate residual
leaks, and ICE revealed 2 trivial and 1 mild leaks.
Arrhythmias affected fewer patients in group II than
in group I. In group I, 8 patients developed a transient
heart block, and 4 developed transient supraventricular
tachycardia secondary to TEE manipulation. In group
II, 2 patients developed transient heart block, and 2
developed transient supraventricular tachycardia sec-
ondary to ICE manipulation. No embolization or
migration of the septal occluder occurred after the
ASD was closed.
Discussion
Accurate measurement of the size of an ASD is essential
for successful transcatheter device closure. Until now,
interatrial septal defect sizing and appropriate device
selection with ICE versus conventional methods have
not been compared in published large series. Our data
confirm improvements in the accuracy, efficacy, and
safety of ICE for sizing interatrial septal defects and for
guiding transcatheter device closure of ASDs (Figure 1).
Conventional TTE can normally detect the ASD,
but it does not achieve optimal imaging in some adults
with obesity, chest deformities, or previous surgical
trauma. TTE is limited by progressive beam attenua-
tion and scattering as ultrasound waves pass through
tissues.15 Sometimes, TTE may lead to underestima-
tion of the actual size and number of defects, or it
may suggest false-positive interatrial shunting shad-
ows, especially when the interatrial septum is not seen
perpendicularly in the subcostal view16,17 and traced
in the oblique or modified 4-chamber view. Angio-
cardiography cannot provide a well-defined shape or
detailed endocardiac characterization of the defect and
its surrounding structures.
A balloon-sizing maneuver and 2-dimensional TEE
have long been regarded as the criterion standard for
measuring ASDs and for guiding selection of the size of
the occluder. In addition, it is a helpful imaging tech-
nique for real-time monitoring of transcatheter closure,
and is widely accepted.5,6 Although few authors have
questioned whether the size of a defect can be accurately
measured with balloon sizing, avoidance of overstretch-
ing of the defect could prevent overestimating the size
of the ASD and choosing an occluder of improper
size.18,19 Today, our institution and most medical centers
still use the balloon-sizing maneuver as the standard for
measuring moderate or large ASDs.
TEE imaging is superior to traditional TTE and
angiocardiography because it provides more information
regarding the anatomy of the defect, the surrounding
structures, and the relationship between the device and
septum.5,7 However, TEE has some disadvantages
because general anesthesia and endotracheal intubation
are typically required, because it increases the risk for
aspiration, and because airway obstruction is a poten-
tial complication. Other risks are pharyngeal injury,
esophageal injury, and gastric perforation during TEE
manipulation. An additional expert echocardiographer
is needed to interpret the TEE images. Although TEE
offers multiple imaging planes, the point of its imaging
source is relatively fixed with respect to the interatrial
septum. Although TEE can be moved by means of
insertion, withdrawal, flexion, anteflexion, or rotation,
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the resultant locations do not typically permit imaging
of the complete interatrial septum in the near field or
in the inferior septum.11
At present, ICE is increasingly used in interventional
electrophysiology and catheterization.20 It is a relatively
new method for evaluating intracardiac lesions, and it
substantially improves imaging resolution of the atrial
septal morphology over that of TTE and TEE.21–25
ICE imaging from the right atrium can be used to
determine the location of the ASD, to estimate the size
and number of defects, to accurately assess the entire
atrial septum (including the superior and inferior fatty
limbus and fossa ovalis membrane), and to directly
visualize the surrounding structures and drainage of
the pulmonary veins. For investigating atrial defects
in the inferior portion of the septum, ICE is much
better than TEE.24,25 In contrast to TEE, the point of
the ICE imaging source can be moved to different
parts of the right atrium to allow imaging of the atrial
septum from different angles; therefore, it is proven to
be superior to TTE and TEE in detecting additional
ASDs. ICE enables us to select an appropriately sized
J Chin Med Assoc • August 2008 • Vol 71 • No 8 403
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Figure 1. Comparison of the different atrial septal defect sizing methods with sizing-plate diameter. (A) Intracardiac echocardiography
(ICE) versus sizing-plate diameter. (B) Transesophageal echocardiography (TEE) versus sizing-plate diameter. (C) Angiocardiography versus
sizing-plate diameter. (D) Transthoracic echocardiography (TTE) versus sizing-plate diameter.
device and to visualize the trans-septal passage of the
catheter, sizing of the balloon, and device deployment.
Moreover, ICE eliminates the need for general anes-
thesia and endotracheal intubation, prevents addi-
tional transesophageal echocardiographic imaging, and
shortens fluoroscopy and procedure times.8,11,13,22
Regarding the disadvantages of ICE, the cost of the
catheter may be an important limitation to its use.
However, ICE is still likely to be cost-effective, as it
eliminates the expense and risk of anesthesia and the
need for an anesthesiologist and another cardiologist
to operate the TEE probe, and it reduces catheterization
laboratory time and procedure time. Limitations also
include the 9F and 10F catheters, which cannot be used
in children who weigh less than 12 kg. Miniaturization
of this technology should overcome this problem, and
the use of small puncture sheaths will lessen trauma to
the femoral vein. Other limitations are monoplanar
imaging and the lack of a wide field of view. These
factors sometimes make visualization of the maximal
diameter of the defect, catheter, and device deployment
challenging. If the measured size of the defect is not its
maximal diameter, the predicted sizing-plate diameter
is underestimated. Future development of biplanar and
multiplanar phased-array transducers—or of real-time,
3-dimensional intracardiac transducers—could replace
current technologies26 and increase the accuracy of
measuring ASDs and estimating sizing-plate diameters
while providing a virtual reality-type of imaging during
transcatheter interventions.
From our study, the patients’ ages and body weights
differed significantly between the ICE and TEE groups,
likely because the young patients tended to be distrib-
uted to group I. However, mean ASD, balloon-
stretched, and sizing-plate diameters were similar, as
were the mean diameters of the selected devices. There-
fore, we could compare the characteristics of defect
sizing between the ICE and TEE groups. Correlation
was better between stretched sizing-plate diameters and
ICE-measured nonstretched ASDs than with TTE,
angiocardiographic or TEE results. We used the ICE
diameter of the ASD to estimate the sizing-plate diam-
eter, and both correlation and agreement between the
predicted and measured diameters were excellent.
In patients in whom the measured balloon-stretched
diameter was ≤ 20 mm, the measurement of the sizing-
plate diameter was more subjective than in others
because of trivial differences in the balloon waist, with
increments or decrements of 1 mm. However, for
those whose measured balloon-stretched diameter
was > 20 mm, the equation used to predict the sizing-
plate diameter with ICE was relatively objective but
had certain biases. The reason may be because of an
increment or decrement of 2 mm in selecting devices
> 20 mm. Moreover, some defects > 20 mm had a rim
deficiency or a floppy rim, and we needed a device
that was 1 or 2 sizes larger than that predicted from
the sizing-plate diameter calculated with the ICE equa-
tion to prevent underestimation and residual shunts.
If the measured size of the defect was not its maximal
diameter, the predicted sizing-plate diameter was also
underestimated.
In conclusion, ASDs measured with ICE had the
best correlation and agreement with the measured
sizing-plate sizes. ICE facilitated all stages of device
closure and monitoring of the deployment process. ICE
was a relatively effective and safe alternative to TEE
during transcatheter ASD closure procedures, leading to
high occlusion rates similar to those with conventional
methods. We recommend using ICE imaging and
equation-based calculations to predict the sizing-plate
diameter of ASDs. In addition, invasive balloon sizing
may not be necessary for transcatheter closure of ASDs
< 20 mm. Further study is necessary to demonstrate
the benefit of calculations derived from ICE equation
in patients with ASDs > 20 mm.
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